3506 POSTER Clinical Characteristics and Outcome of Treatment of Brazilian Women With Breast Cancer Treated at Public and Private Institutions by Hegg, R, Mattar, A, Emereciano, K, Pinotti, M, Perdicaris, M, van Eyll, B, Franke, F, Pinczowski, H, Freitas, R, Jendiroba, D

Get full text

A phase II trial of fractionated vinorelbine/ doxorubicin as first-line therapy for advanced breast cancer by HEGG, R, COSTA, M. A, CORREA, M, NADER, L, ANDRADE, C, PERDICARIS, M, DELGADO, G. L, CABRAL-FILHO, S, MALZYNER, A, CAPONERO, R, YAMAGUSHI, N, NOVAES, N, ANELLI, A

Get full text

P3-07-37: Clinical Characteristics and Treatment of Brazilian Women with Breast Cancer at Public and Private Institutions by Hegg, R, Mattar, A, Gebrim, LH, Emerenciano, K, Pinotti, M, Perdicaris, M, van, Eyll B, Franke, F, Pinczowski, H, Freitas, R, Jendiroba, D, Borges, G, Queiroz, G, Nascimento, YV, Gampel, O, Mathias, C, Budel, V, Strepassos, E, Delgado, G

Get full text

PCN34 COST MINIMIZATION ANALYSIS OF INTRA-VENOUS BIPHOSPHONATES THERAPIES AVAILABLE IN BRAZIL FOR THE PROPHYLAXIS OF SKELETAL EVENTS (SE) IN BREAST CANCER PATIENTS WITH BONE METAST... by Perdicaris, M, Nasciben, V, Saggia, MG

Get full text

PCN17 COST-EFFECTIVENESS ANALYSIS OFTRASTUZUMAB THERAPY IN PATIENTS WITH EARLY HER-2 POSITIVE BREAST CANCER IN BRAZIL by Correa, M, Perdicaris, M, Vernaglia, PRW, Da Cunha, FM, Saggia, MG, Santos, EA, Nasciben, V

Get full text

A pilot study with navelbine (NVB) + fractionated doxorubicin (DX) as neo-adjuvant chemotherapy for locally advanced breast cancer by Albuquerque, R., Segalla, J., Perdicaris, M., Delgado, G.

Get full text

Improvement in quality of life (QoL) and ECOG in a cohort of 1125 patients (pts) with metastatic breast cancer (MBC) treated with capecitabine (X) by Beato, C., Tosello, C., Ribeiro, R., Cabral, S., Tessaro, S., Lago, S., Abdo, E., Moura, G., Perdicaris, M., Garicochea, B.

Get full text

446 Quality of life (QoL) in patients with metastatic breast cancer (MBC) treated with capecitabine (Xeloda) by Segalla, G., Oliveira, C.T., Lago, S., Ribeiro, R., Guimarães, R., Cabral, S., Letchakoski, G., Federico, M.H., Bines, J., Perdicaris, M.

Get full text

300 Effects of capecitabine (Xeloda) on quality of life (QoL) in patients with metastatic colorectal cancer (MCRC) by Beato, C.A., Federico, M.H., Cabral, S., Duarte, R.C., Van Eyll, B., Carvalho, M.P., Lago, S., Medeiros, E., Perdicaris, M., Machado, D.

Get full text

A Phase II Trial of Fractionated Vinorelbine/Doxorubicin as First-line Therapy for Advanced Breast Cancer by Hegg, R., Costa, M. A., Perdicaris, M., Delgado, G. L., Cabral-Filho, S., Malzyner, A., Caponero, R., Yamagushi, N., Novaes, N., Anelli, A., Correa, M., Nader, L., Andrade, C.

Get full text

Evaluation of Quality of Life in Patients with Metastatic Colorectal Cancer Treated with Capecitabine by Segalla, José G.M, Van Eyll, Brigitte, Honda Federico, Mirian Hatsue, Skare, Nills G, Franke, Fábio A, Perdicaris, Martha R, de Paula Filho, Urias, Gampel, Otávio, Cabral, Sebastião, de Albuquerque Ribeiro, Ronaldo

Get full text